← Back to Search

Homeopathic Medicine

Homeopathic Medication for Post-COVID Syndrome

Phase 3

Waitlist Available

Led By Elizabeth Rice, ND

Research Sponsored by Southwest College of Naturopathic Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 4, 8 and 12 weeks

Awards & highlights

Pivotal Trial

Summary

This trial aims to see if homeopathic medicine can help improve fatigue and quality of life for patients with Post-acute COVID-19 Syndrome. The treatment uses tiny amounts of natural substances to stimulate the body's healing. Researchers hope to gather enough data to justify a larger study.

Eligible Conditions

Post-COVID Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 4, 8 and 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 4, 8 and 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4, 8 and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Fatigue Assessment Scale (FAS)

SF-36 Mental Composite Score (MCS)

SF-36 Physical Composite Score (PCS)

Secondary study objectives

Measure Yourself Medical Outcomes Profile Symptom #1

Measure Yourself Medical Outcomes Profile Symptom #2

Patient Doctor Depth of Relationship (PDDR)

+1 more

Side effects data

From 2022 Phase 3 trial • 77 Patients • NCT05104749

Urinary Tract Infection

Musculoskeletal Pain

Headache

Upper Respiratory Tract Infection

Vaccine Injury

Insomnia

100%

80%

60%

40%

20%

Study treatment Arm

Homeopathic Treatment Group

Placebo Group

Awards & Highlights

Pivotal Trial

The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Homeopathic Treatment GroupExperimental Treatment1 Intervention

Individualized homeopathic medicines on impregnated lactose pellets will be prescribed to each participant based on the totality of their physical, emotional, and mental symptoms. All medicines prescribed are listed in the Homeopathic Pharmacopoeia of the United States (HPUS) as outlined in the Food, Drug, and Cosmetics Act of 1939

Group II: Placebo GroupPlacebo Group1 Intervention

Identical lactose pellets in size, odor, and taste without the impregnated homeopathic medicines.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Homeopathic Medication

2016

Completed Phase 3

~140

Do I qualify?Apply below to find out